CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pruschy, M.
Right arrow Articles by Krek, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pruschy, M.
Right arrow Articles by Krek, W.
Cell Growth & Differentiation Vol. 10, 141-146, March 1999
© 1999 American Association for Cancer Research

E2F-1 Has Properties of a Radiosensitizer and Its Regulation by Cyclin A Kinase Is Required for Cell Survival of Fibrosarcoma Cells Lacking p531

Martin Pruschy, Christiane Wirbelauer, Christoph Glanzmann, Stephan Bodis and Wilhelm Krek2

Department of Radiation Oncology, University Hospital Zürich, CH-8091 Zürich [M. P., C. G., S. B.]; and Friedrich Miescher Institut, CH-4058 Basel [C. W., W. K.], Switzerland

Negative regulation of E2F-1 DNA binding function by cyclin A kinase represents part of an S-phase checkpoint control system that, when activated, leads to apoptosis. In this study, we examined the cellular sensitivity and resistance of isogenic mouse fibrosarcoma cell lines, differing primarily in their p53 status, to ectopic expression of wild-type (wt) E2F-1 and cyclin A kinase binding-defective mutants of it. We found that E2F-1(wt) potently affected the survival of p53+/+ tumor cells but not that of p53-/- cells. In contrast, expression of cyclin A kinase binding-defective E2F-1 species interfered with cell survival of fibrosarcoma cells irrespective of their p53 status. Finally, expression of E2F-1(wt) in p53-/- fibrosarcoma cells enhanced the cytotoxic effect of ionizing radiation in vitro and in vivo in a mouse tumor model. These results suggest that E2F-1-dependent activation of an S-phase checkpoint is p53 independent and that E2F-1 possesses radiosensitizing properties in the absence of p53.




This article has been cited by other articles:


Home page
J Biol ChemHome page
J. C. Paik, B. Wang, K. Liu, J. K. Lue, and W.-C. Lin
Regulation of E2F1-induced Apoptosis by the Nucleolar Protein RRP1B
J. Biol. Chem., February 26, 2010; 285(9): 6348 - 6363.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
T. S. Udayakumar, P. Hachem, M. M. Ahmed, S. Agrawal, and A. Pollack
Antisense MDM2 Enhances E2F1-Induced Apoptosis and the Combination Sensitizes Androgen-Dependent and Androgen-Independent Prostate Cancer Cells to Radiation
Mol. Cancer Res., November 1, 2008; 6(11): 1742 - 1754.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Lee, C. K. Park, J. O. Park, T. Lim, Y. S. Park, H. Y. Lim, I. Lee, T. S. Sohn, J. H. Noh, J. S. Heo, et al.
Impact of E2F-1 Expression on Clinical Outcome of Gastric Adenocarcinoma Patients with Adjuvant Chemoradiation Therapy
Clin. Cancer Res., January 1, 2008; 14(1): 82 - 88.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Wang, F. J. Rauscher III, W. D. Cress, and J. Chen
Regulation of E2F1 Function by the Nuclear Corepressor KAP1
J. Biol. Chem., October 12, 2007; 282(41): 29902 - 29909.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Hofstetter, V. Vuong, A. Broggini-Tenzer, S. Bodis, I. F. Ciernik, D. Fabbro, M. Wartmann, G. Folkers, and M. Pruschy
Patupilone Acts as Radiosensitizing Agent in Multidrug-Resistant Cancer Cells In vitro and In vivo
Clin. Cancer Res., February 15, 2005; 11(4): 1588 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Jiang, C. B. Matranga, D. Cai, V. M. Latham Jr., X. Zhang, A. M. Lowell, F. Martelli, and G. I. Shapiro
Flavopiridol-Induced Apoptosis during S Phase Requires E2F-1 and Inhibition of Cyclin A-Dependent Kinase Activity
Cancer Res., November 1, 2003; 63(21): 7410 - 7422.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
P. F. de Borja, N. K. Collins, P. Du, J. Azizkhan-Clifford, and M. Mudryj
Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription
EMBO J., October 15, 2001; 20(20): 5737 - 5747.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Zaugg, S. Rocha, H. Resch, I. Hegyi, C. Oehler, C. Glanzmann, D. Fabbro, S. Bodis, and M. Pruschy
Differential p53-dependent Mechanism of Radiosensitization in Vitro and in Vivo by the Protein Kinase C-specific Inhibitor PKC412
Cancer Res., January 1, 2001; 61(2): 732 - 738.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1999 by the American Association of Cancer Research.